GlassScriptPhysician profile
Glen T Stuhring
NPI 1275515702
$6,302.00
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,447 · 2020: $1,842 · 2021: $2,013.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,154.73 | 2019-2021 | |
| Pfizer INC. | $806.10 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $785.59 | 2019-2021 | |
| Amgen INC. | $556.46 | 2019-2021 | |
| Gilead Sciences, INC. | $351.19 | 2019-2021 | |
| Lilly USA, LLC | $233.90 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $216.90 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $204.33 | 2019-2020 | |
| Glaxosmithkline, LLC. | $201.09 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $191.88 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $182.83 | 2019-2021 | |
| Novo Nordisk INC | $169.53 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $166.94 | 2019-2021 | |
| Astellas Pharma US INC | $164.75 | 2020-2021 | |
| Otsuka America Pharmaceutical, INC. | $154.08 | 2019-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $107.76 | 2019-2021 | |
| Abbvie INC. | $85.93 | 2021 | |
| Esperion Therapeutics, INC. | $84.56 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $78.05 | 2019-2021 | |
| Antares Pharma, INC. | $64.20 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $53.22 | 2019 | |
| Amarin Pharma, INC. | $50.51 | 2021 | |
| Merck Sharp & Dohme LLC | $45.77 | 2020-2021 | |
| Allergan, INC. | $32.47 | 2019-2020 | |
| Phadia US INC. | $29.12 | 2020 | |
| Jazz Pharmaceuticals INC. | $28.98 | 2019 | |
| Shire North American Group INC | $24.97 | 2019 | |
| Lundbeck LLC | $20.56 | 2021 | |
| Abbott Laboratories | $20.46 | 2019 | |
| Ironshore Pharmaceuticals INC. | $18.27 | 2019 | |
| Organon LLC | $16.87 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glen Stuhring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.